# Efficacity and Safety of Metformin XR in CKD Stage 1 to 3

> **NCT02895750** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 12 (actual)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02895750
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-30
- **Primary completion:** 2022-01-08
- **Final completion:** 2022-10-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02895750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02895750, "Efficacity and Safety of Metformin XR in CKD Stage 1 to 3". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02895750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*